SRF and cancer: For example, increased MAMs formation in cancer cells leads to elevated cytosolic Ca2+ levels, promoting the phosphorylation of serum response factor (SRF) and enhancing the binding of SRF to the VEGFR2 promoter, resulting in increased VEGFR2 production and subsequent angiogenesis.